Home ›
Organizations ›
NNH QALICB
NNH QALICB
NV · Disease Research · EIN 473098270
1
Executives Disclosed
$80K
Annual Revenue
$37.9M
Total Assets
NNH QALICB has 1 executive with disclosed compensation. The highest-paid executive, Sharon Chamberlain (CEO), received peak total compensation of $284,951. The sector average for Disease Research executives is $215K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Sharon Chamberlain | CEO | $285K | $285K | 2022–2024 | 3.8x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2022 | 1 | $244K | $244K | $244K |
| 2023 | 1 | $266K | $266K | $266K |
| 2024 | 1 | $285K | $285K | $285K |
Email Alerts
Get notified about NNH QALICB
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.